Early-drug development in the era of immuno-oncology: are we ready to face the challenges?
Ann Oncol
.
2019 Oct 1;30(10):1670.
doi: 10.1093/annonc/mdz211.
Authors
M O Ochoa de Olza
,
M Oliva
,
C Hierro
,
I Matos
,
J Martin-Liberal
,
E Garralda
PMID:
31406973
DOI:
10.1093/annonc/mdz211
No abstract available
Publication types
Published Erratum